Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 24 of 35

COMPLETED NA

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

NCT01716169

COMPLETED Phase 4

The Influence of Chronic CMV Infection on Influenza Vaccine Responses

NCT02134184

COMPLETED NA

Pivotal Response Treatment for Individuals With Intellectual Disabilities

NCT01988623

COMPLETED

PK/PD Modeling of Magnesium in the Mother and Neonate

NCT01709630

COMPLETED NA

Text Messaging for Adherence in Adolescent Liver Transplant Recipients

NCT01696331

COMPLETED NA

Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times

NCT01802008

COMPLETED NA

Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being

NCT01694303

COMPLETED NA

Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD

NCT01694316

COMPLETED NA

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

NCT01477463

COMPLETED NA

California Transport Cooling Trial

NCT01683383

COMPLETED NA

Brain Imaging of rTMS Treatment for Depression

NCT01829165

TERMINATED

NK Cell Mediated Influenza Immunity During Pregnancy

NCT03196245

COMPLETED NA

Chemical Ice Packs for Cooling Hyperthermic Patients

NCT01694290

COMPLETED

Rates of Apnea in Patients Undergoing Vitreoretinal Surgery

NCT01745341

COMPLETED NA

Clinic, Family & Community Intervention for Children With Overweight and Obesity (Stanford GOALS)

NCT01642836

COMPLETED NA

Vascular Health and Exercise Performance of Overweight Children

NCT01729273

COMPLETED

Epilepsy Impact Scale

NCT01833234

COMPLETED

Lactic Acidosis During and After Seizures

NCT01833247

COMPLETED Phase 2

Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

NCT01771666

COMPLETED

Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

NCT01727999

TERMINATED

Cancer Biology of Retinoblastoma

NCT01642823

COMPLETED Phase 2

Intranasal Oxytocin Treatment for Social Deficits in Children With Autism

NCT01624194

COMPLETED Early Phase 1

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

NCT01631331

COMPLETED Phase 2

Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee

NCT01645176

COMPLETED

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)

NCT01637415

COMPLETED NA

Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

NCT01680653

COMPLETED NA

Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks

NCT01615731

TERMINATED NA

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

NCT01541358

TERMINATED Phase 1

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

NCT01528137

COMPLETED

Genetic Basis of Rosacea

NCT02787616

COMPLETED NA

Weight Loss Diet Study: Low Carb vs Low Fat

NCT01661426

COMPLETED

Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease

NCT01749813

TERMINATED Phase 1

Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

NCT01494012

COMPLETED NA

Post Photorefractive Keratectomy (PRK) Use of an Eye Shield for Maintaining Vision and Mitigating Pain

NCT01592643

COMPLETED NA

Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

NCT01536977

COMPLETED NA

Early Screening and Treatment of Women With Prediabetes in Pregnancy

NCT01552213

COMPLETED

Assessment of Patient Experience During Treatment for Cancer

NCT01553825

COMPLETED

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

NCT01546363

COMPLETED Phase 1

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

NCT01660607

COMPLETED Phase 4

Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients

NCT01619982

COMPLETED NA

Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery

NCT01509950

COMPLETED

Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration

NCT01526070

COMPLETED Phase 3

Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects

NCT01802073

COMPLETED Phase 4

Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension

NCT05439460

COMPLETED

Reading in Preterm and Full-term Children: Neural Basis and Prediction

NCT01599546

COMPLETED NA

Comparative Outcomes Management With Electronic Data Technology (COMET) Study

NCT01461473

COMPLETED NA

Medtronic Treat to Range (TTR) Closed-Loop Control

NCT01490151

COMPLETED

Stanford's Outcomes Research in Kids

NCT01442701

COMPLETED Phase 4

Pioglitazone in Patients With Mood Disorders

NCT01559857

COMPLETED

Evaluation of a Non-invasive Brain Compliance Measurement Device

NCT01753921

← Previous Page 24 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.